Literature DB >> 30855427

The Distributional Characteristic and Growing Trend of Pancreatic Cancer in China.

Chengfei Zhao, Feng Gao1, Quwen Li2, Qicai Liu3, Xinhua Lin4.   

Abstract

Pancreatic cancer is a malignant tumor with difficulty in diagnosis and treatment and was the sixth leading cause of cancer death among both men and women in China. The 5-year relative survivals of pancreatic cancer were only 7.2% in China and the lowest level in all cancers. The proportion of estimated new cases of pancreatic cancer in China was comparatively high in East China, Northeast, North China, and Northwest and relatively low in Central China, Southwest, and South China, showing obvious regional characteristics. It implies that the incidence and mortality in the eastern region are significantly higher than those in the western region, which is consistent with the result that the incidence and mortality increased from low to middle to high urbanization areas in China, and the prevalence of diabetes increased from underdeveloped to intermediately developed to developed region.

Entities:  

Mesh:

Year:  2019        PMID: 30855427     DOI: 10.1097/MPA.0000000000001222

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  12 in total

1.  Identification of a glycolysis-related gene signature for predicting pancreatic cancer survival.

Authors:  Jiachao Zhang; Zhehao Liu; Zhensheng Zhang; Rong Tang; Yongchao Zeng; Pingping Chen
Journal:  J Gastrointest Oncol       Date:  2022-02

2.  Integrated Analysis of Glutathione Metabolic Pathway in Pancreatic Cancer.

Authors:  Xingui Wu; Ruyuan Yu; Meisongzhu Yang; Yameng Hu; Miaoling Tang; Shuxia Zhang; Ainiwaerjiang Abudourousuli; Xincheng Li; Ziwen Li; Xinyi Liao; Yingru Xu; Man Li; Suwen Chen; Wanying Qian; Rongni Feng; Jun Li; Fenjie Li
Journal:  Front Cell Dev Biol       Date:  2022-06-03

Review 3.  Herbals and Plants in the Treatment of Pancreatic Cancer: A Systematic Review of Experimental and Clinical Studies.

Authors:  John K Triantafillidis; Eleni Triantafyllidi; Michail Sideris; Theodoros Pittaras; Apostolos E Papalois
Journal:  Nutrients       Date:  2022-01-30       Impact factor: 5.717

4.  Reproductive Factors, Use of Exogenous Hormones, and Pancreatic Cancer Incidence: The Norwegian Women and Cancer Study.

Authors:  Antoine Alvarez; Kristin Benjaminsen Borch; Charlotta Rylander
Journal:  Clin Epidemiol       Date:  2021-02-05       Impact factor: 4.790

5.  Magnolol Suppresses Pancreatic Cancer Development In Vivo and In Vitro via Negatively Regulating TGF-β/Smad Signaling.

Authors:  Shuo Chen; Jiaqi Shen; Jing Zhao; Jiazhong Wang; Tao Shan; Junhui Li; Meng Xu; Xi Chen; Yang Liu; Gang Cao
Journal:  Front Oncol       Date:  2020-12-02       Impact factor: 6.244

6.  Conversion therapy, palliative chemotherapy and surgery, which of these is the best treatment for locally advanced and advanced pancreatic cancer?

Authors:  Mingxing Wang; Pengfei Zhu; Zheling Chen; Liu Yang
Journal:  Anticancer Drugs       Date:  2022-01-01       Impact factor: 2.248

7.  The NF-κB/miR-488/ERBB2 axis modulates pancreatic cancer cell malignancy and tumor growth through cell cycle signaling.

Authors:  Duo Han; Shaihong Zhu; Xia Li; Zhiqiang Li; Hui Huang; Wenzhe Gao; Yunfei Liu; Hongwei Zhu; Xiao Yu
Journal:  Cancer Biol Ther       Date:  2022-12-31       Impact factor: 4.875

8.  Clinical Study of Anti-PD-1 Immunotherapy Combined with Gemcitabine Chemotherapy in Multiline Treatment of Advanced Pancreatic Cancer.

Authors:  Yanfeng Liu; Yanchuan Li; Shan Du; Li Fan; Junyan Wang
Journal:  Comput Math Methods Med       Date:  2022-09-06       Impact factor: 2.809

9.  MicroRNA-4516 suppresses pancreatic cancer development via negatively regulating orthodenticle homeobox 1.

Authors:  Shuo Chen; Meng Xu; Jing Zhao; Jiaqi Shen; Junhui Li; Yang Liu; Gang Cao; Jiancang Ma; Weizhou He; Xi Chen; Tao Shan
Journal:  Int J Biol Sci       Date:  2020-05-18       Impact factor: 6.580

10.  Qualitative Transcriptional Signature for the Pathological Diagnosis of Pancreatic Cancer.

Authors:  Yu-Jie Zhou; Xiao-Fan Lu; Jia-Lin Meng; Xin-Yuan Wang; Xin-Jia Ruan; Chang-Jie Yang; Qi-Wen Wang; Hui-Min Chen; Yun-Jie Gao; Fang-Rong Yan; Xiao-Bo Li
Journal:  Front Mol Biosci       Date:  2020-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.